Company Description
Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies.
The fund structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity.
The fund prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications.
The fund seeks to invest in the United States. The fund primarily invests between $5 million and $75 million in companies having EBITDA of $2 million or greater and revenues between $5 million and $250 million.
The fund prefers to take a majority stake. The fund invests through direct lending as well as participation in loan syndicates.
Country | United States |
Founded | 2007 |
IPO Date | Mar 23, 2007 |
Industry | Asset Management |
Sector | Financials |
CEO | Christian Oberbeck |
Contact Details
Address: 535 Madison Avenue, Fourth Floor New York, New York 10022 United States | |
Phone | 212 906 7800 |
Website | saratogainvestmentcorp.com |
Stock Details
Ticker Symbol | SAR |
Exchange | NYSE |
Stock Type | Common Stock |
Fiscal Year | March - February |
Reporting Currency | USD |
CIK Code | 0001377936 |
CUSIP Number | 80349A208 |
ISIN Number | US80349A2087 |
Employer ID | 20-4876925 |
Key Executives
Name | Position |
---|---|
Christian Long Oberbeck | Chairman, President and Chief Executive Officer |
Henri J. Steenkamp | Chief Compliance Officer, Secretary, Treasurer, Chief Financial Officer and Director |
Michael Joseph Grisius | Co-Managing Partner and Chief Investment Officer |
Adam Prior | Senior Vice President |
Richard A. Petrocelli CPA | Managing Director |
Paul B. West | Managing Director |
Marissa Mann Andrews | Principal |
Thomas V. Inglesby J.D. | MD and Portfolio Manager |
John F. MacMurray | MD and Portfolio Manager |
Charles G. Phillips IV | MD and Portfolio Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 5, 2025 | DEF 14A | Other definitive proxy statements |
Jul 8, 2025 | 8-K | Current Report |
Jul 8, 2025 | 10-Q | Quarterly Report |
Jul 2, 2025 | SCHEDULE 13G/A | Filing |
May 7, 2025 | 8-K | Current Report |
May 7, 2025 | 10-K | Annual Report |
Jan 13, 2025 | 40-17G | Filing |
Jan 8, 2025 | 8-K | Current Report |
Jan 8, 2025 | 10-Q | Quarterly Report |
Oct 23, 2024 | 8-K | Current Report |